Giles D. Major
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Building lifelines: A narrative review and pragmatic implementation framework for developing centralised adult chronic intestinal failure services.
Journal: Clinical nutrition ESPEN
Published: January 23, 2026
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden.
Journal: Mayo Clinic proceedings. Digital health
Published: June 26, 2025
An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors.
Journal: Gut microbiome (Cambridge, England)
Published: August 23, 2024
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.
Journal: NIHR open research
Published: August 13, 2024
A focus group study to assess perspectives of patients with irritable bowel syndrome on human milk oligosaccharides and lifestyle insights.
Journal: European journal of nutrition
Published: August 02, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 01, 2024
What Does Healthy Microbiome Development Look Like? State of the Art and Beyond.
Journal: Nestle Nutrition Institute workshop series
Published: February 12, 2024
Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 22, 2024
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Journal: Microbiology spectrum
Published: August 22, 2023
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review.
Journal: Expert review of gastroenterology & hepatology
Published: June 06, 2023
Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
Journal: Gut
Published: December 22, 2021
Last Updated: 09/26/2026